Medley Therapeutics, Inc.
PrivateLast Round
Series B
Jan 12, 2022
Total Funding Raised
$30.6M
Company Overview
Medley Therapeutics, Inc. is a biotechnology company that develops regenerative genetic medicines and advanced biologics to treat severe diseases such as heart failure, fibrotic diseases, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medley Therapeutics, Inc. Comparables
Compare Medley Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivace Therapeutics | 86% | |
| Renova Therapeutics | 84% | |
| Tenaya Therapeutics | 81% | |
Medley Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 12, 2022 | ||||
| Seed | Mar 1, 2021 |
Medley Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fjord Ventures | Series B |
| ArrowMark Partners | Series B |
| Alexandria Venture Investments | Seed |
| BCM Ventures | Series B |
| Alexandria Venture Investments | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2022
$30M round with participation from ArrowMark Partners and Fjord Ventures.
Medley Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Medley Therapeutics, Inc.'s valuation, stock price, and market status.